Iris Moll

3.8k citations

28 papers · 2.5k indexed · 1 hit paper · h-index 19

Impact in

Oncology top 5%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Molecular Biology 16
- Developmental Biology and Gene Regulation 3
- Melanoma and MAPK Pathways 2
Oncology 9
- Cutaneous Melanoma Detection and Management 3
- CAR-T cell therapy research 3
- Cancer Cells and Metastasis 2

Co-authors: Antje Sucker (10 shared papers)Dirk Schadendorf (10 shared papers)Susanne Horn (2 shared papers)Eduardo Nagore (2 shared papers)Rajiv Kumar (2 shared papers)Kari Hemminki (2 shared papers)Andreas Gast (1 shared paper)Adina Figl (1 shared paper)
Journals: EMBO Molecular Medicine (3 papers)PLoS ONE (3 papers)Clinical Cancer Research (2 papers)Nature Communications (2 papers)Allergy (1 paper)
Partner nations: Germany United States Spain

In The Last Decade

Iris Moll

28 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

TERT Promoter Mutations in Familial and Sporadic Melanoma 2013 · 1.3k citations

Peers

Countries citing papers authored by Iris Moll

Since Specialization

Citations

This map shows the geographic impact of Iris Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Moll more than expected).

Fields of papers citing papers by Iris Moll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Moll. The network helps show where Iris Moll may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Moll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Moll Line = papers co-authored together Iris Moll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	TERT Promoter Mutations in Familial and Sporadic Melanoma Science ·Susanne Horn, Adina Figl, P. Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar Hit paper breakdown →	2013	1267
2	Endothelial Notch1 Activity Facilitates Metastasis Cancer Cell ·Elfriede Wieland, Juan Rodríguez‐Vita, Sven S. Liebler, Carolin Mogler, Iris Moll, Stefanie E. Herberich, Elisa Espinet, Esther Herpel, Amitai Menuchin, Jenny Chang‐Claude, Michael Hoffmeister, Christoffer Gebhardt, Hermann Brenner, Andreas Trumpp, Christian W. Siebel, Markus Hecker, Jochen Utikal, David Sprinzak, Andreas Fischer	2017	232
3	Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B Clinical Cancer Research ·Annette Paschen, Antje Sucker, Bettina Hill, Iris Moll, Marc Zapatka, Xuan Duc Nguyen, Geok Choo Sim, Isabelle Gutmann, Jessica C. Hassel, Jürgen C. Becker, Alexander Steinle, Dirk Schadendorf, Selma Ugurel	2009	147
4	Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression Clinical Cancer Research ·Antje Sucker, Fang Zhao, Birgit Real, Christina Heeke, Nicola Bielefeld, Stefan Maβen, Susanne Horn, Iris Moll, Raffaela Maltaner, Peter A. Horn, Bastian Schilling, Francesco Sabbatino, Volker Lennerz, Matthias Kloor, Soldano Ferrone, Dirk Schadendorf, Christine S. Falk, Klaus Griewank, Annette Paschen	2014	127
5	Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus British Journal of Dermatology ·Ulrich R. Hengge, W. Kŕause, Heidelore Hofmann, R Stadler, Gary N. Gross, M. Meurer, Thomas Brinkmeier, Peter J. Frosch, Iris Moll, Peter Fritsch, Katharina Müller, Nuschin Meykadeh, Alessandra Marini, Thomas Ruzicka, Harald Gollnick	2006	86
6	Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cells International Journal of Cancer ·Nicole Schwinn, Daria Vokhminova, Antje Sucker, Sonja Textor, Sandra Striegel, Iris Moll, Norman Nausch, Jochen Tuettenberg, Alexander Steinle, Adelheid Cerwenka, Dirk Schadendorf, Annette Paschen	2008	78
7	TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma PLoS ONE ·Klaus Griewank, Rajmohan Murali, Bastian Schilling, Tobias Schimming, Inga Möller, Iris Moll, Marion Schwamborn, Antje Sucker, Lisa Zimmer, Dirk Schadendorf, Uwe Hillen	2013	73
8	Genetic and clinico-pathologic analysis of metastatic uveal melanoma Modern Pathology ·Klaus Griewank, Johannes van de Nes, Bastian Schilling, Iris Moll, Antje Sucker, Hojabr Kakavand, Lauren E. Haydu, Marina Asher, Lisa Zimmer, Uwe Hillen, John F. Thompson, Richard A. Scolyer, Dirk Schadendorf, Rajmohan Murali	2013	68
9	Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes Stroke ·Gerald Bastian Schulz, Elfriede Wieland, Joycelyn Wüstehube‐Lausch, Gwénola Boulday, Iris Moll, Elisabeth Tournier‐Lasserve, Andreas Fischer	2015	57
10	Ketone body oxidation increases cardiac endothelial cell proliferation EMBO Molecular Medicine ·Eva‐Maria Weis, Patrycja Puchalska, Alisa B. Nelson, Jacqueline Taylor, Iris Moll, Sana S. Hasan, Matthias Dewenter, Marco Hagenmüller, Thomas Fleming, Gernot Poschet, Agnes Hotz‐Wagenblatt, Johannes Backs, Peter A. Crawford, Andreas Fischer	2022	45
11	pHH3 Immunostaining Improves Interobserver Agreement of Mitotic Index in Thin Melanomas American Journal of Dermatopathology ·Tobias Schimming, Florian Grabellus, Mathias Roner, Sonali Pechlivanis, Antje Sucker, Nicola Bielefeld, Iris Moll, Dirk Schadendorf, Uwe Hillen	2011	42
12	Loss of Mpdz impairs ependymal cell integrity leading to perinatal‐onset hydrocephalus in mice EMBO Molecular Medicine ·Anja Feldner, Mohamed Adam, Fabian Tetzlaff, Iris Moll, Dorde Komljenovic, Felix Sahm, Tobias Bäuerle, Hiroshi Ishikawa, Horst Schroten, Thomas Korff, Ilse Hofmann, Hartwig Wolburg, Andreas von Deimling, Andreas Fischer	2017	39
13	MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome British Journal of Cancer ·(unknown), J.C. Hassel, Antje Sucker, Lutz Edler, Hjalmar Kurzen, Iris Moll, Carlo Stresemann, Konstanze Spieth, Cornelia Mauch, Knuth Rass, Reinhard Dummer, Dirk Schadendorf	2010	38
14	MPDZ promotes DLL4-induced Notch signaling during angiogenesis eLife ·Fabian Tetzlaff, Mohamed Adam, Anja Feldner, Iris Moll, Amitai Menuchin, Juan Rodríguez‐Vita, David Sprinzak, Andreas Fischer	2018	32
15	Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis Oncogene ·Ralph Klose, Mohamed Adam, Eva‐Maria Weis, Iris Moll, Joycelyn Wüstehube‐Lausch, Fabian Tetzlaff, Chio Oka, Michael Ehrmann, Andreas Fischer	2018	27
16	HAPLN1 potentiates peritoneal metastasis in pancreatic cancer Nature Communications ·Lena Wiedmann, Francesca Rigotti, Nuria Vaquero‐Siguero, Elisa Donato, Elisa Espinet, Iris Moll, Elisenda Alsina‐Sanchís, Hanibal Bohnenberger, Elena Fernández-Florido, Ronja Mülfarth, Margherita Vacca, Jennifer Gerwing, Lena‐Christin Conradi, Philipp Ströbel, Andreas Trumpp, Carolin Mogler, Andreas Fischer, Juan Rodríguez‐Vita	2023	24
17	Endothelial Notch signaling controls insulin transport in muscle EMBO Molecular Medicine ·Sana S. Hasan, Markus Jabs, Jacqueline Taylor, Lena Wiedmann, Thomas Leibing, Viola Nordström, Giuseppina Federico, Letícia Prates Roma, Christopher Carlein, Gretchen Wolff, Bilgen Ekim Üstünel, Maik Brune, Iris Moll, Fabian Tetzlaff, Hermann‐Josef Gröne, Thomas Fleming, Cyrill Géraud, Stephan Herzig, Peter P. Nawroth, Andreas Fischer	2020	21
18	Intraperitoneal Oil Application Causes Local Inflammation with Depletion of Resident Peritoneal Macrophages Molecular Cancer Research ·Elisenda Alsina‐Sanchís, Ronja Mülfarth, Iris Moll, Carolin Mogler, Juan Rodríguez‐Vita, Andreas Fischer	2020	20
19	Semiquantitative Aspects of Mast Cells in Normal Skin and in Neurofibromas of Neurofibromatosis Types 1 and 5 Dermatology ·M. Nürnberger, Iris Moll	1994	20
20	Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis Cardiovascular Research ·Ralph Klose, Caroline Berger, Iris Moll, Mohamed Adam, Frank Schwarz, Kerstin Möhr, Hellmut G. Augustin, Andreas Fischer	2015	18

About Iris Moll

Iris Moll is a scholar working on Molecular Biology, Oncology, Immunology, Neurology and Dermatology, having authored 28 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (3 papers), CAR-T cell therapy research (3 papers), Developmental Biology and Gene Regulation (3 papers), Melanoma and MAPK Pathways (2 papers), Cancer Cells and Metastasis (2 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (881 citations), Cancer Research (450 citations), Aging (48 citations), Immunology (543 citations) and Molecular Biology (1.3k citations). Iris Moll has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Antje Sucker, Dirk Schadendorf, Susanne Horn, Eduardo Nagore, Rajiv Kumar, Kari Hemminki, Andreas Gast, Adina Figl, P. Sivaramakrishna Rachakonda and Christine Fischer. Their work appears in journals such as EMBO Molecular Medicine, PLoS ONE, Clinical Cancer Research, Nature Communications and Allergy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact